Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ADAM17 | P78536 | 4/20 | 0.33 |
| ▸ | NAMPT | P43490 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.32 |
| ▸ | SMO | Q99835 | 1/20 | 0.32 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16731017 | 0.84 | MEN1 (0.40) | MAPTADAM17SMN1; SMN2ROCK2SMO | |
| SCHEMBL18128798 | 0.84 | MEN1 (0.40) | MAPTADAM17SMN1; SMN2ROCK2SMO | |
| SCHEMBL16730951 | 0.73 | KDM4E (0.47) | MAPTADAM17NAMPTSMN1; SMN2ROCK2 | |
| SCHEMBL16730950 | 0.73 | GRM5 (0.44) | MAPTROCK2CYP11B1CYP11B2 | |
| SCHEMBL20170507 | 0.72 | EHMT2 (0.36) | GAAROCK2CYP11B1CYP11B2ALDH1A1 | |
| SCHEMBL16719039 | 0.72 | FKBP1A (0.42) | ROCK2 | |
| SCHEMBL16719063 | 0.71 | GRM5 (0.42) | ROCK2 | |
| SCHEMBL16718979 | 0.70 | CYP11B2 (0.39) | MAPTCYP11B1CYP11B2 | |
| SCHEMBL16720932 | 0.69 | RIPK1 (0.39) | ADAM17ROCK2ALDH1A1 | |
| SCHEMBL16730880 | 0.65 | NTRK1 (0.39) | MAPTSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3068391-B1 | ARYL LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG | MERCK SHARP & DOHME (US) | 2018-05-23 | — | — | EP | disclosed |